2018 - Neoantigens for Personalized Cancer Vaccines: Comprehensive Identification and Effective Selection
Date2018-06-18
Deadline2018-06-17
VenueOnline, Canada
KeywordsCancer Vaccine Development; Biomarker Discovery; Bioinformatics
Topics/Call fo Papers
Topics to be discussed during this webinar will include:
*Technical overview of ACE ImmunoID including augmentation and validation
*Review of bioinformatics deliverables and analytical modules including HLA Typing, Similarity-to-Self, Similarity-to-Known-Antigens, and Tumor Immunogenomics
*Case study demonstrating ACE ImmunoID’s further utility in biomarker discovery through identifying methods of tumor escape in patients treated with checkpoint modulators
*Best practices for designing rapid, patient-centric processes for vaccine clinical trials including optimizing sample preparation and integrating lab automation
*Technical overview of ACE ImmunoID including augmentation and validation
*Review of bioinformatics deliverables and analytical modules including HLA Typing, Similarity-to-Self, Similarity-to-Known-Antigens, and Tumor Immunogenomics
*Case study demonstrating ACE ImmunoID’s further utility in biomarker discovery through identifying methods of tumor escape in patients treated with checkpoint modulators
*Best practices for designing rapid, patient-centric processes for vaccine clinical trials including optimizing sample preparation and integrating lab automation
Other CFPs
- A Case Study of Using an Accelerated Approach to Migrate to a Hosted Pharmacovigilance Solution
- Blockchain Beyond Cryptocurrency: Applying Blockchain Technology to the Life Sciences
- The Future of eCOA: A Panel Discussion
- Organ-on-a-Chip: Improving Preclinical Studies for Faster Drug Development
- Legalized Marijuana & Maintaining a Drug Free Workplace
Last modified: 2018-05-17 04:34:42